Download - FDA Drug Safety Podcast: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq) | Podbean

Discover

Podcast Features
Your all-in-one podcasting solution.

Blog to Podcast
Turn your blog into an engaging podcast.
Livestream
High-performing audio live, without limits.

Podcast Studio
Easy-to-use audio recorder app.
Podbean AI
AI-Enhanced Audio Quality and Content Generation.

Podcast App
The best podcast player & podcast app.

Ads Marketplace
Join Ads Marketplace to earn money
through sponsorship on your podcast.

PodAds
Manage your ads with dynamic ad insertion capability.
Apple Podcasts Subscriptions Integration
Effortlessly publish and manage exclusive episodes for your
Apple Podcasts subscribers directly from Podbean.
Live Streaming
Receive livestream rewards from your audience and earn
recurring income from your Fan Club membership.

All Arts Business Comedy Education
Fiction Government Health & Fitness History Kids & Family
Leisure Music News Religion & Spirituality Science
Society & Culture Sports Technology True Crime TV & Film
Live

How to Start a Podcast
How to Start a Live Podcast
How to Monetize a podcast
How to Promote Your Podcast
How to Use Group Recording

Log in
Start your podcast for free

Podcasting
Monetization
Advertisers
Enterprise
Pricing
Discover

Log in

Sign up free

FDA Drug Safety Podcasts

Health & Fitness:Medicine

FDA Drug Safety Podcast: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq)

2018-05-24

Download Right click and do "save link as"

FDA Drug Safety Communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq)

view more

More Episodes

FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause

2024-09-20

FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)

2024-02-06

Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

2024-01-26

FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)

2023-12-08

FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

2023-05-31

FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use

2023-05-10

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)

2022-12-16

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)

2022-07-27

FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns

2022-07-07

FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging

2022-04-13

FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)

2022-02-09

FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

2022-01-24

FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury

2021-11-09

FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions

2021-09-08

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins

2021-07-22

FDA warns that vapors from alcohol-based hand sanitizers can have side effects

2021-06-21

Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) patients with advanced cirrhosis

2021-06-03

Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease

2021-04-02

FDA warns that abuse and misuse of the OTC nasal decongestant propylhexedrine can lead to serious harm

2021-03-29

Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)

2021-02-08

←
1
2
3
→

012345678910111213141516171819

Get this podcast on your
phone, FREE

Download Podbean app on App Store

Download Podbean app on Google Play

Create your
podcast in
minutes

Full-featured podcast site
Unlimited storage and bandwidth
Comprehensive podcast stats
Distribute to Apple Podcasts, Spotify, and more
Make money with your podcast

Get started

It is Free

Podcast Services
MONETIZATION & MORE
KNOWLEDGE BASE
Support
Podbean

Privacy Policy
Cookie Policy
Terms of Use
Consent Preferences
Copyright © 2015-2024 Podbean.com